Aortic stenosis (AS) is the most prevalent valvular heart disease in developed countries, primarily affecting the elderly population [ ]. Its traditional hemodynamic assessment distinguishes between high-gradient AS and low-flow low-gradient (LF-LG) AS, the latter presenting a complex diagnostic and therapeutic challenge [ , ]. This paradoxical presentation complicates the decision-making process, particularly regarding the indication and timing for aortic valve replacement (AVR). Transcatheter aortic valve replacement (TAVR) has emerged as a revolutionary treatment for severe AS, particularly for those at intermediate to high surgical risk [ ].